# Pramipexole ER vs. Placebo in Fibromyalgia

> **NCT00689052** · PHASE2 · TERMINATED · sponsor: **Boehringer Ingelheim** · enrollment: 61 (actual)

## Conditions studied

- Fibromyalgia

## Interventions

- **DRUG:** pramipexole ER
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00689052
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-07
- **Primary completion:** 2008-11
- **Final completion:** —
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2014-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00689052

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00689052, "Pramipexole ER vs. Placebo in Fibromyalgia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00689052. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*